Proquin Xr

Yersinia pestis, Urinary tract infection, acute otitis externa caused by Staphylococcus aureus + 56 more
Treatment
35 FDA approvals
20 Active Studies for Proquin Xr

What is Proquin Xr

CiprofloxacinThe Generic name of this drug
Treatment SummaryCiprofloxacin is an antibiotic that works to fight a wide range of bacterial infections. The drug was approved by the FDA in 1987 and can be taken orally, intravenously, through the ear, or through the eye. Ciprofloxacin has been used to treat numerous bacterial infections and is considered a reliable and effective antibiotic.
Ciprois the brand name
Proquin Xr Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Cipro
Ciprofloxacin
1987
590

Approved as Treatment by the FDA

Ciprofloxacin, also known as Cipro, is approved by the FDA for 35 uses such as Febrile Neutropenia and Communicable Diseases .
Febrile Neutropenia
Used to treat Febrile Neutropenia in combination with Piperacillin
Communicable Diseases
inhaled anthrax caused by Bacillus anthracis
prostatitis
Cystitis
UTI caused by methicillin-susceptible Staphylococcus epidermidis
Urinary Tract Infections
Lower respiratory tract infection caused by Escherichia coli
Sinusitis
Proteus mirabilis
Lower respiratory tract infection caused by Haemophilus parainfluenzae
Urinary tract infection
Lower respiratory tract infection caused by penicillin-susceptible Streptococcus pneumoniae
Salmonella typhi
Osteomyelitis
UTI caused by Citrobacter diversus
Urinary tract infection
Serratia marcescens
Cystitis
Urinary tract infection
Gonorrhea
Escherichia coli
Urinary Tract Infections
Haemophilus influenzae
Pseudomonas aeruginosa
Proteus mirabilis
Infectious diarrhea
Klebsiella pneumoniae
Moraxella catarrhalis
Helps manage Acute Exacerbations of Chronic Bronchitis caused by Moraxella catarrhalis
Escherichia coli
Escherichia coli
Urinary tract infection
Lower respiratory tract infection caused by Enterobacter cloacae
Abdominal Infection
Used to treat Complicated Intra-Abdominal Infections (cIAIs) in combination with Metronidazole
Klebsiella pneumoniae

Effectiveness

How Proquin Xr Affects PatientsCiprofloxacin is a type of antibiotic that is used to treat many different kinds of bacterial infections. It works by stopping the bacteria from being able to reproduce and spread, and has a strong effect on bacteria that other antibiotics can no longer fight. It has also been studied for its potential to treat malaria, cancer, and AIDS.
How Proquin Xr works in the bodyCiprofloxacin works by targeting the molecules that help bacterial DNA replicate. It stops these molecules from supercoiling the DNA, which stops the bacteria from being able to make new copies of itself.

When to interrupt dosage

The endorsed measure of Proquin Xr relies upon the diagnosed affliction, including Proteus mirabilis, Conjunctivitis and Cystitis. The dosage fluctuates, depending on the technique of delivery (e.g. Kit; Powder, for suspension - Oral or Kit; Suspension) featured in the table underneath.
Condition
Dosage
Administration
Urinary Tract Infections
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Communicable Diseases
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Urinary tract infection
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
inhaled anthrax caused by Bacillus anthracis
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Conjunctivitis caused by Haemophilus influenzae
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Serratia marcescens
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Pseudomonas aeruginosa
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Urinary tract infection
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
UTI caused by methicillin-susceptible Staphylococcus epidermidis
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Lower respiratory tract infection caused by Enterobacter cloacae
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Haemophilus influenzae
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Lower respiratory tract infection caused by penicillin-susceptible Streptococcus pneumoniae
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Salmonella typhi
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Plague
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Communicable Diseases
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Pyelonephritis
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Healthcare-Associated Pneumonia
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Febrile Neutropenia
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Otitis Media, Suppurative
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic
Ear Inflammation
, 2.0 mg/mL, 10.0 mg/mL, 500.0 mg, 3.0 mg/mL, 425.2 mg, 250.0 mg, 287.5 mg, 750.0 mg, 3.5 mg/mL, 40.0 mg/mL, 5.0 mg/mL, 574.9 mg, 212.6 mg, 1000.0 mg, 0.3 %, 100.0 mg, 6.0 mg/mL, 20.0 mg/mL, 0.003 mg/mg, 0.2 %, 60.0 mg/mL, 100.0 mg/mL, 50.0 mg/mL, 3.5 mg, 500.1 mg, 1000.1 mg, 4.0 mg/mL, 500.0 mg/mL, 6.0 mg/mg, 400.0 mg, 250.0 mg/mL, 200.0 mg, 7.5 mg/mL
Auricular (otic), , Suspension, Suspension - Auricular (otic), Injection, solution, concentrate, Injection, solution, concentrate - Intravenous, Intravenous, Injection, solution, Injection, solution - Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Injection - Intravenous, Injection, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Ophthalmic; Topical, Solution / drops - Ophthalmic; Topical, Solution, Solution - Ophthalmic, Solution / drops - Auricular (otic), Topical, Solution / drops - Topical, Tablet, coated, Tablet, coated - Oral, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Liquid, Liquid - Intravenous, Intratympanic, Suspension - Intratympanic, Suspension / drops, Suspension / drops - Auricular (otic), Solution, concentrate, Solution, concentrate - Intravenous, Kit, Ointment, Ointment - Ophthalmic, Suspension - Oral, Solution - Auricular (otic), Kit - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Auricular (otic); Intratympanic, Suspension - Auricular (otic); Intratympanic

Warnings

Proquin Xr Contraindications
Condition
Risk Level
Notes
External auditory canal structure
Do Not Combine
Fungal ear infection
Do Not Combine
Pulse Frequency
Do Not Combine
perforated eardrum
Do Not Combine
Pulse Frequency
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Ciprofloxacin may interact with Pulse Frequency
There are 20 known major drug interactions with Proquin Xr.
Common Proquin Xr Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be decreased when combined with Ciprofloxacin.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Ciprofloxacin.
Acetaminophen
Major
The metabolism of Acetaminophen can be decreased when combined with Ciprofloxacin.
Acyclovir
Major
The metabolism of Acyclovir can be decreased when combined with Ciprofloxacin.
Agomelatine
Major
The serum concentration of Agomelatine can be increased when it is combined with Ciprofloxacin.
Proquin Xr Toxicity & Overdose RiskOverdosing on Ciprofloxacin can cause nausea, vomiting, stomach pain, kidney stones, and reduced urine output. It can also lead to kidney failure and may require prednisone, dialysis, or supportive treatments. Depending on the severity of the overdose, normal kidney function may be recovered or the patient may develop chronic kidney failure. The lowest toxic dose in rats is over 2000mg/kg. There is generally no harm to the fetus from ciprofloxacin, although high doses may increase the chance of miscarriage in the mother. It has been shown to be non-carcinogenic and
image of a doctor in a lab doing drug, clinical research

Proquin Xr Novel Uses: Which Conditions Have a Clinical Trial Featuring Proquin Xr?

Zero active clinical trials are currently assessing the utility of Proquin Xr in combating Pseudomonas aeruginosa, Escherichia coli and Cystitis.
Condition
Clinical Trials
Trial Phases
Tympanostomy tube insertion
0 Actively Recruiting
Urinary tract infection
0 Actively Recruiting
Otitis
2 Actively Recruiting
Not Applicable
Yersinia pestis
0 Actively Recruiting
Cystitis
0 Actively Recruiting
Otitis
0 Actively Recruiting
Pseudomonas aeruginosa
0 Actively Recruiting
Gonorrhea
0 Actively Recruiting
inhaled anthrax caused by Bacillus anthracis
0 Actively Recruiting
Urinary Tract Infections
0 Actively Recruiting
Plague
0 Actively Recruiting
Corneal Ulcers caused by Staphylococcus aureus
0 Actively Recruiting
acute otitis externa caused by Staphylococcus aureus
0 Actively Recruiting
UTI caused by methicillin-susceptible Staphylococcus epidermidis
0 Actively Recruiting
Lower respiratory tract infection caused by Enterobacter cloacae
0 Actively Recruiting
Communicable Diseases
0 Actively Recruiting
Communicable Diseases
2 Actively Recruiting
Phase 2, Not Applicable
Urinary tract infection
0 Actively Recruiting
Lower respiratory tract infection caused by Haemophilus parainfluenzae
0 Actively Recruiting
Otitis Media, Suppurative
0 Actively Recruiting

Patient Q&A Section about proquin xr

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is ciprofloxacin hcl used for urinary tract infections?

"Ciprofloxacin extended-release tablets are only effective against urinary tract infections, including acute uncomplicated pyelonephritis. Proquin® XR tablets are only effective against uncomplicated or simple urinary tract infections (acute cystitis). Ciprofloxacin is a member of the class of drugs known as quinolone antibiotics."

Answered by AI

What are Proquin XR tablets?

"Proquin XR is a prescription medicine used to treat the symptoms of different types of bacterial infections. Proquin XR may be used alone or with other medications. Proquin XR is classed as a Fluoroquinolone, and its safety and effectiveness has not been established in children."

Answered by AI

What are the symptoms of ciprofloxacin?

"Stop taking ciprofloxacin and call your doctor immediately if you experience any of the following symptoms: numbness, tingling, pain, burning, or weakness in the arms or legs; or a change in your ability to feel light touch, vibrations, pain, heat, or cold."

Answered by AI

What is ciprofloxacin hydrochloride used to treat?

"such as chlamydia,

The antibiotic azithromycin is used to treat infections including chest and bone infections, as well as sexually transmitted infections (STIs) such as chlamydia."

Answered by AI

Clinical Trials for Proquin Xr

Have you considered Proquin Xr clinical trials? We made a collection of clinical trials featuring Proquin Xr, we think they might fit your search criteria.
Have you considered Proquin Xr clinical trials? We made a collection of clinical trials featuring Proquin Xr, we think they might fit your search criteria.
Have you considered Proquin Xr clinical trials? We made a collection of clinical trials featuring Proquin Xr, we think they might fit your search criteria.